Sickle cell disease

• A study to test how either a capsule or a tablet with NDec (Decitabine and Tetrahydrouridine) works in the body of healthy people Not authorised
  2023-504582-22-00 1 "Sickle Cell Disease"
• MOOD - MethOxyflurane analgesia in vasoOcclusive crises of sickle cell Disease Not authorised
  2024-518043-38-00 5
• Lidocaine for opioid sparing in vaso-occlusive crisis of Sickle Cell Disease Pending
  2024-518437-28-00 5
• A Single Arm, Open Label, Phase 1/2 Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients with Sickle Cell D … Pending
  2024-519881-32-00 9 "Sickle Cell Disease"
• Morphine PCA vs Morphine and Lidocaine PCA for the treatment of vaso-occlusive crisis-related pain in sickle-cell anaemia patients: a prospe … Pending
  2025-523777-41-01 6 "sickle cell anaemia"
• The efficacy and safety of rilzabrutinib in participants aged 10 to 65 years with sickle-cell disease Recruiting
  2024-518645-17-00 5 2025-10-07 "Blood and lymphatic diseases"
• Pharmacokinetics, Efficacy and Safety of Twice Daily Dosing Regimen of Hydroxycarbamide Dispersible Tablets in Children with Sickle Cell Dis … Recruiting
  2024-513750-30-00 4 2026-03-25 "Sickle Cell Disease"
• A Phase 1/2 Open Label Cohort Comparative Study Evaluating the Efficacy and the safety of Gene Therapy of the Sickle Cell Disease by Transpl … Recruiting
  2025-521257-17-00 7 2026-02-25 "SCD severe patients"
• TOCIACS : Efficacy and safety of Tocilizumab for acute chest syndrome treatment in paediatric and adult patients with sickle cell disease Recruiting
  2023-505109-17-00 5 2025-08-27
• A Phase 1/2a, First-in-human Study to Evaluate BMS-986470 in Healthy Volunteers and Participants with Sickle Cell Disease Recruiting
  2023-510283-12-00 7 2025-06-12 "Sickle Cell Disease"
• Long-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transdu … Recruiting
  2024-513901-30-00 5 2020-11-03 "Sickle-cell disease"
• Study of two doses of crizanlizumab versus placebo in adolescent and adult sickle cell disease patients Recruiting
  2023-508689-14-00 5 2019-09-16
• This study is a randomized, placebo-controlled, double-blind, multicenter Phase 2/3 study of patients, age 12 to 65 years, with sickle cell … Recruitment ended
  2024-511535-97-00 10 2021-12-16 "sickle cell disease (SCD)"
• Rollover Study for Patients with Sickle Cell Disease who have Completed a prior Novartis-Sponsored Crizanlizumab Study Recruitment ended
  2024-510734-41-00 6 2021-06-10
• A study of mitapivat in sickle cell disease Recruitment ended
  2024-515569-32-00 4 2020-09-24
• A Phase 2/3 Study in Adult and Pediatric Participants with SCD Suspended
  2023-508766-14-00 10 "Sickle Cell Disease"
• A Study Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso‑O … Ended
  2022-502546-26-00 3 2023-09-11 "Sickle Cell Disease"
• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Oc … Ended
  2022-502542-28-00 4 2021-12-06 "Sickle Cell Disease"
• A Clinical Study of Mitapivat in Patients with Sickle Cell Disease and Kidney Disease Ended
  2023-510289-28-00 4 "Sickle Cell Disease (SCD) and Nephropathy"

Showing 1–19 of 19 trials